The use of disease-modifying antirheumatic drugs (DMRADs) such as hydroxychloroquine or tumor necrosis factor inhibitor for lowering the inflammatory response in patients with RA has been shown to reduce the risk of developing diabetes [23], [24]. The gene discussed is TNF; the disease is diabetes mellitus.